PubMed COVID-19 Clinical Care
49831 - 49840 of 58327 results found
Impact of coronavirus disease 2019 on consumers' perceptions of genetically modified food
Description
The coronavirus disease 2019 (COVID-19) pandemic has generated significant economic loss and an unprecedented challenge to people's livelihoods. Using household data collected in November 2020, this study shows that the COVID-19 outbreak has
Interactions between carbon nanotubes and external structures of SARS-CoV-2 using molecular docking and molecular dynamics
Description
Molecular modeling techniques are used to describe the process of interaction between nanotubes and the main structures of the Covid-19 virus: the envelope protein, the main protease, and the Spike glycoprotein. Molecular docking studies show that
COVID-19 triggered residential behavioral changes and electricity consumption of detached houses in Japan
Description
Many studies conducted previously have reported that due to lockdowns or stay-at-home orders associated with the COVID-19 pandemic in April 2020 residential power consumption has increased in countries, particularly in cities worldwide. This study
SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patients
Description
Patients with COVID-19 may develop abnormal inflammatory response, followed in some cases by severe disease and long-lasting syndromes. We show here that in vitro exposure to SARS-CoV-2 activates the expression of the human endogenous retrovirus
COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China
Description
As the COVID-19 variant Omicron surge in Beijing, China, a better understanding of risk factors for adverse outcomes may improve clinical management in patients with haematological malignancies (HM) diagnosed with COVID-19. The study sample includes
Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination
Description
Anti-SARS-CoV-2 vaccines were developed in response to the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although the BNT162b2 mRNA vaccine is effective, adverse effects have been
Monoclonal Antibodies for COVID-19 in X-linked Agammaglobulinemia: a Case Series
Description
No abstract
Effectiveness of patient triage at the orthopedic hospital and the hygiene concept in a professional handball team in the first year of the SARS-CoV-2 pandemic
Description
The first severe acute respiratory syndrome coronavirus type 2 (SARS-CoV‑2) pandemic wave in Germany in spring 2020 challenged the largely unprepared healthcare system. A prevention concept was implemented to protect the vulnerable patient group at
Telehealth: Navigating the COVID-19 Pandemic and Beyond: The Sickle Cell Unit Experience
Description
Introduction: To examine the use of telehealth for delivery of health care in persons with sickle cell disease in a resource-constrained country during the COVID-19 pandemic. Methods: This study was a retrospective review of patient encounters at the
